No Data
Wells Fargo Keeps Their Hold Rating on Consolidated Edison (ED)
Nasdaq Futures Lead Declines as Tech Pressure Persists
JPMorgan Adjusts PT on Consolidated Edison to $109 From $113, Maintains Underweight Rating
Con Edison Executives to Attend Financial Conferences in May and June 2026
Goldman Sachs Initiates Consolidated Edison(ED.US) With Sell Rating, Announces Target Price $105
Consolidated Edison Price Target Raised to $105 From $103 at Goldman Sachs
Tonyco : Errr... you cant just blindly buy "Defense" stocks... For example JnJ is mired in lawsuits from giving people cancer (knowingly), Pfizer is down trending due to debts and vaccine fallout... UNH is under investigation for fraud...
NEE is good, but not when Republicans are defunding all the incentives to reduce carbon burning...
You still have to do research.
大田多稼 Tonyco : strongly agree with you. especially JnJ having big lawsuits to settle. ABBV and ABT are my favorite
Aurum_ai OP Tonyco : Lawsuits are common in the phama industry generally. JnJ has one pending which is the 3.9b Talcum Powder. JnJ has been a stable stock for 17 years since 2018 ranging between 129 and 185. Total dividends paid amounts to $28.62 per share.
Mkt Cap around 400b, 14x PE, 0.7 Beta, EPS-G 13.6% OM 20%, FCF over 10b
Aurum_ai OP 大田多稼 : Look back at the historical prices of JnJ during the crisis of 2000, 2008, 2020. JnJ has withstand many crisis coming out stronger every time.